Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome.

about

Spotlight on eluxadoline for the treatment of patients with irritable bowel syndrome with diarrhea.Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System.

P2860

Q42184351-3BAA620C-503E-4617-9783-B6BA6F01DB4D Q55252194-F53A7003-B02C-4AE3-BB0A-CE195AB1D656

P2860

Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome.

Item

http://www.wikidata.org/entity/Q39298126

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome.

@en

Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome.

@nl

type

Item

label

Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome.

@en

Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome.

@nl

prefLabel

Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome.

@en

Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome.

@nl

P1476

Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome.

@en

P2860

Early response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies.

Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use.

Effect of uptake transporters OAT3 and OATP1B1 and efflux transporter MRP2 on the pharmacokinetics of eluxadoline.

Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/ µ opioid receptor antagonist.

Sphincter of Oddi Function and Risk Factors for Dysfunction.

Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea.

Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus.

American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation.

Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers.

P2888

s40265-017-0756-7

P304

1009-1016

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-017-0756-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gillian M Keating

P577

2017-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28493170

http://www.w3.org/2001/XMLSchema#string

P921

Afọ ọsịsa

Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome.

about

P2860

P2860

Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921